by Agilent Technologies
Polaris HPLC Columns
Performs Well Under Aqueous Conditions
In areas like drug discovery where target compounds are increasingly polar, it is critical to have a reversed-phase column that performs well under aqueous conditions. Retention is critical, but cannot come with troublesome secondary interactions. Likewise, phase collapse and shifting retention times need to be avoided. The answer is our Polaris line of polar modified columns.
| Vendor | Agilent Technologies | Pore size | 180 |
| Brand | Agilent Polaris | pH stability to | 10.0 |
| Modifification | Silica/C8 | Surface Area | 200 |
| Mode | Reversed-Phase | Carbon Load, % | 7.4 |
| Particle Size | Endcapped | Yes | |
| Length | Operating Temperature | 60 | |
| Internal Diameter |
| Vendor | Brand | Mode | Modification | Int. diam. | Length | Particles | Pores | Price |
|---|---|---|---|---|---|---|---|---|
| Higgins Analytical | CLIPEUS C8 | Reversed-Phase | Silica/C8 | 0.8 mm | 100 mm | 5.0 μm | 120 Å | On request |
| SGE Analytical Science | ProteCol C8 H (Stainless Steel) | Reversed-Phase | Silica/C8 | 2.1 mm | 150 mm | 3.0 μm | 120 Å | On request |
| Sepax Technologies | Sepax Bio 300 C8 | Reversed-Phase | Silica/C8 | 0.3 mm | 50 mm | 3.0 μm | 300 Å | On request |
| LabHut | Cronusil-P C8 | Reversed-Phase | Silica/C8 | 4.0 mm | 200 mm | 5.0 μm | 300 Å | 386.50 |
| ES Industries | Chromegabond 500 MC-8 | Reversed-Phase | Silica/C8 | 2.0 mm | 100 mm | 5.0 μm | 500 Å | On request |
| CERI | L-column2 C8 | Reversed-Phase | Silica/C8 | 4.6 mm | 100 mm | 3.0 μm | 120 Å | On request |
| Agilent Technologies | Original ZORBAX | Reversed-Phase | Silica/C8 | 4.0 mm | 150 mm | 5.0 μm | 70 Å | On request |
| ES Industries | Chromegabond 100 C8 | Reversed-Phase | Silica/C8 | 4.0 mm | 150 mm | 5.0 μm | 100 Å | On request |
No customer reviews yet. Be the first to share your experience!